Displaying drugs 14876 - 14900 of 15302 in total
Motexafin lutetium
Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational
Alphamethadol
Experimental
Illicit
4-Flourobenzenesulfonamide
Experimental
AL5424
Experimental
3-Amino-4-Oxybenzyl-2-Butanone
Experimental
Phenylacetaldehyde
Experimental
AL7089A
Experimental
Benzylamine
Experimental
4-(Hydroxymethyl)Benzamidine
Experimental
1,3-Dinitrobenzene
Experimental
Para-Bromobenzyl Alcohol
Experimental
DAS869
Experimental
4-Fluorobenzylamine
Experimental
2,6-Difluorobenzenesulfonamide
Experimental
1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea
Experimental
3-Iodo-Benzyl Alcohol
Experimental
3,3',5,5'-tetrachlorobiphenyl-4,4'-diol
Experimental
4-(trifluoromethyl)phenol
Experimental
2-Iodobenzylthio Group
Experimental
N-phenylthiourea
Experimental
AL6528
Experimental
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol
Experimental
Displaying drugs 14876 - 14900 of 15302 in total